IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY
Author(s) -
A. A. Tarasova,
Е. В. Колбасина,
Е. Ф. Лукушкина,
Yu.G. Kuzmichev,
М. П. Костинов
Publication year - 2016
Publication title -
вопросы современной педиатрии
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v15i5.1623
Subject(s) - seroconversion , medicine , immunogenicity , immunoadjuvant , vaccination , influenza vaccine , virus , influenza a virus , antibody , virology , adverse effect , hemagglutination assay , antibody titer , inactivated vaccine , titer , immunology , adjuvant
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom